TipRanks
Go Ultimate55% OFF

Aarti Surfactants Ltd. (AARTISURF) AI Stock Analysis

IN:AARTISURF

Aarti Surfactants Ltd.

(NSE:AARTISURF)

Select Model
Rating:66Neutral
Price Target:INR 505.00▲(10.78% Upside)
Action:reiterated
Date:08/05/26

Driven by moderate financial performance with revenue growth offset by margin volatility, supported by bullish technicals despite overbought risks; valuation appears fair but unremarkable.

Positive Factors
Revenue RecoveryThe return to meaningful revenue growth indicates improved demand for the company’s surfactants and specialty chemicals after a weak prior year. Sustained top-line recovery can support better asset utilization, broaden customer relationships, and provide a foundation for rebuilding earnings over the next several quarters.
Negative Factors
Gross Margin CompressionThe sharp decline in gross margin signals weaker economics on the company’s product sales and suggests limited ability to retain higher input costs through pricing. If margins remain depressed, revenue growth may translate poorly into profit and constrain the company’s capacity to reinvest in growth.

Aarti Surfactants Ltd. (AARTISURF) vs. iShares MSCI India ETF (INDA)

-40%-20%0%20%40%60%IN:AARTISURF+1.28%INDA-12.02%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
INR 3.86B
Dividend Yield
0.22%
Average Volume (3M)
4,088
Price to Earnings (P/E)
21.0
Beta (1Y)
1.83
Revenue Growth
25.22%
EPS Growth
20.38%
Country
India
Employees
393
Sector
General
Sector Strength
55
Industry
Chemicals - Specialty

Aarti Surfactants Ltd. Business Overview & Revenue Model

Company Description

Aarti Surfactants Limited, in conjunction with its subsidiary Aarti HPC Limited, specializes in the production and global distribution of a diverse range of surfactants, including ionic, non-ionic, and specialty types. These crucial chemical compound...

How the Company Makes Money

Aarti Surfactants Ltd. primarily makes money by manufacturing and selling surfactants and allied specialty chemical products to business customers (B2B). Revenue is generated from (1) sales of surfactants and surfactant intermediates used as inputs b...

Aarti Surfactants Ltd. Financial Statement Overview

Summary

Solid revenue growth and strengthening balance sheet with reduced leverage, but volatile margins and fluctuating cash flows indicate moderate financial health.

Income Statement

55Neutral

Balance Sheet

75Positive

Cash Flow

65Positive
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue9.16B8.59B6.59B5.86B5.97B5.70B
Gross Profit1.18B947.78M1.25B990.42M1.23B794.12M
EBITDA560.00M468.81M419.18M621.92M477.40M324.31M
Net Income183.99M123.42M145.45M213.27M127.05M54.95M
Balance Sheet
Total Assets05.17B4.77B4.22B4.02B4.02B
Cash, Cash Equivalents and Short-Term Investments134.31M134.31M12.07M63.15M76.89M14.29M
Total Debt01.04B1.10B992.09M1.49B1.62B
Total Liabilities-2.45B2.72B2.45B2.04B2.36B2.67B
Stockholders Equity2.45B2.45B2.33B2.18B1.68B1.36B
Cash Flow
Free Cash Flow-8.16M201.22M-90.98M356.08M139.31M7.76M
Operating Cash Flow216.41M652.27M111.38M519.61M247.84M233.18M
Investing Cash Flow-239.22M-450.85M-161.63M-162.19M85.61M-225.41M
Financing Cash Flow16.49M-79.18M-3.67M-371.15M-270.86M-60.80M

Aarti Surfactants Ltd. Technical Analysis

Technical Analysis SentimentPositive
Last Price455.85

Price Trends

50DMA508.74Negative
100DMA467.93Negative
200DMA430.08Positive

Market Momentum

MACD-13.54Positive
RSI44.20Neutral
STOCH40.79Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:AARTISURF, the sentiment is Positive. The current price of 455.85 is below the 20-day moving average (MA) of 480.31, below the 50-day MA of 508.74, and above the 200-day MA of 430.08, indicating a neutral trend. The MACD of -13.54 indicates Positive momentum. The RSI at 44.20 is Neutral, neither overbought nor oversold. The STOCH value of 40.79 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:AARTISURF.

Aarti Surfactants Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IN:AARTISURF against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IN:FINEORGIN:FINEORG75OutperformINR 154.84B35.84―0.22%7.26%5.73%
IN:GALAXYSURFIN:GALAXYSURF68NeutralINR 75.16B21.20―1.04%27.05%16.13%
IN:AARTISURFIN:AARTISURF66NeutralINR 3.96B21.00―0.22%25.22%20.38%
IN:ROSSARIIN:ROSSARI65NeutralINR 22.12B14.48―0.13%19.76%11.74%
IN:AVTNPLIN:AVTNPL63NeutralINR 13.38B15.97―0.91%40.77%54.07%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
IN:CAMLINFINEIN:CAMLINFINE30UnderperformINR 16.15B323.46――8.40%―

* General Sector Average

Performance Comparison

-50%-25%0%25%IN:AARTISURFIN:AVTNPLIN:CAMLINFINEIN:FINEORGIN:GALAXYSURFIN:ROSSARIDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
IN:AARTISURF and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IN:AARTISURFAarti Surfactants Ltd.467.55-4.13-0.88%
IN:AVTNPLAVT Natural Products Limited87.8315.0720.71%
IN:CAMLINFINECamlin Fine Sciences Limited84.05-115.70-57.92%
IN:FINEORGFine Organic Industries Ltd.5050.20641.2114.54%
IN:GALAXYSURFGalaxy Surfactants Ltd.2119.80-117.93-5.27%
IN:ROSSARIRossari Biotech Ltd399.25-242.58-37.79%

Aarti Surfactants Ltd. Corporate Events

Aarti Surfactants Widens Business Scope With Revised Memorandum of Association

Oct 1, 2026

Aarti Surfactants Ltd. has secured shareholder approval at its eighth annual general meeting to alter the main object clause of its Memorandum of Association, effectively expanding and clarifying the scope of its permitted business activities in chem...

Aarti Surfactants Holds Eighth AGM with Clean Audit for FY 2025-26

Sep 29, 2026

Aarti Surfactants Ltd. conducted its eighth Annual General Meeting on September 29, 2026 via video conferencing and other audio-visual means, complying with guidance from the Ministry of Corporate Affairs and SEBI. Fifty-eight shareholders participat...

Aarti Surfactants Discloses AGM Investor Presentation to Exchanges

Sep 29, 2026

Aarti Surfactants Limited informed stock exchanges that it delivered an investor presentation to shareholders at its eighth Annual General Meeting held on September 29, 2026. The disclosure, made under SEBI’s listing regulations, underscores th...

Aarti Surfactants Discloses Resignation of Independent Director Nisha B. Shah

Sep 12, 2026

Aarti Surfactants Ltd. has announced the resignation of Mrs. Nisha B. Shah from her role as Non-Executive Independent Director, effective from the close of business on September 11, 2026. The company disclosed that Shah has provided reasons in her re...

Aarti Surfactants Sets Virtual AGM as It Releases FY 2025-26 Annual Report

Sep 4, 2026

Aarti Surfactants Ltd., a listed player in the surfactants and specialty chemicals space, serves home and personal care as well as industrial markets with its portfolio of surface-active agents and related products. Its dual listing on BSE and NSE gi...

Aarti Surfactants Secures Rating Upgrade to Crisil A-/Stable on Rs 200 Crore Bank Facilities

Sep 3, 2026

Aarti Surfactants Ltd., a listed surfactants manufacturer serving home, personal care and industrial markets, disclosed a change in its credit rating agency from CARE Ratings to Crisil Ratings for its bank loan facilities. The company’s access...

Aarti Surfactants sets up wholly owned U.S. subsidiary to expand global reach

Aug 31, 2026

Aarti Surfactants Ltd. has incorporated a wholly owned overseas subsidiary, Precision Ingredients USA Inc., in the State of Wyoming, United States, to handle marketing, import, export, and trading of surfactants, specialty chemicals, and allied produ...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 05, 2026